RAYMOND JAMES & ASSOCIATES - ACER THERAPEUTICS INC ownership

ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 25 filers reported holding ACER THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of ACER THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$37,000
-9.8%
16,2000.0%0.00%
Q3 2021$41,000
-10.9%
16,2000.0%0.00%
Q2 2021$46,000
-8.0%
16,2000.0%0.00%
Q1 2021$50,000
+19.0%
16,2000.0%0.00%
Q4 2020$42,000
-10.6%
16,2000.0%0.00%
Q3 2020$47,000
-16.1%
16,2000.0%0.00%
Q2 2020$56,000
+75.0%
16,2000.0%0.00%
Q1 2020$32,000
-52.2%
16,200
-3.0%
0.00%
Q4 2019$67,000
+26.4%
16,7000.0%0.00%
Q3 2019$53,000
-91.7%
16,700
-89.8%
0.00%
-100.0%
Q2 2019$637,000
-49.5%
163,332
+214.6%
0.00%
-50.0%
Q1 2019$1,262,00051,9220.00%
Other shareholders
ACER THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Nantahala Capital Management 1,136,416$1,049,3670.10%
Anson Funds Management LP 129,795$119,8530.02%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 60,000$550.01%
Hudson Bay Capital Management LP 274,300$253,2890.00%
UBS Group AG 33$300.00%
RHUMBLINE ADVISERS 347$3200.00%
OSAIC HOLDINGS, INC. 200$1840.00%
WELLS FARGO & COMPANY/MN 132$1220.00%
NORTHERN TRUST CORP 22,231$20,5280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ACER THERAPEUTICS INC shareholders